此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Hemodynamic Assessment in Acute Decompensated Heart Failure

2019年3月25日 更新者:Rodin Scientific LLC

Hemodynamic Assessment Throughout Diuretic Treatment in Acute Decompensated Heart Failure

This study will assess the ability of a novel optical measurement system to determine changes in the hemodynamic status of heart failure patients admitted to the hospital with a primary diagnosis of acute decompensated heart failure. Patients will be measured with both the novel measurement system and reference devices that are FDA-cleared for hemodynamic measurements. The measurements from the novel system will be compared to reference variables describing hemodynamic and congestive status, including stroke volume, central venous pressure, and serum levels of NT-proBNP.

研究概览

详细说明

This study will assess the ability of a novel optical measurement system to determine changes in the hemodynamic status of heart failure patients admitted to the hospital with a primary diagnosis of acute decompensated heart failure. Patients will be measured with both the novel measurement system and reference devices that are FDA-cleared for hemodynamic measurements. The measurements from the novel system will be compared to reference variables describing hemodynamic and congestive status, including stroke volume, central venous pressure, and serum levels of NT-proBNP.

All patients enrolled in the study will first provide written informed consent to participate and then the research coordinator will check that the subject meets all study inclusion criteria and does not meet any of the study exclusion criteria. Enrolled subjects will undergo up to six (6) hemodynamic assessment sessions lasting less than 90 minutes each over the course of their hospitalization. There will be at least eight (8) hours between assessment sessions.

Each assessment session includes recording of the subject's weight, measurements with the reference devices, and measurements with the novel optical system. During the session, the subject will be assessed in the supine, sitting, and standing positions. NT-proBNP measurements will be done at the start of study participation and the end. A market research questionnaire will be administered to the subject following the first measurement session.

研究类型

观察性的

注册 (实际的)

5

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Split、克罗地亚、21 000
        • University Hospital of Split
    • New Mexico
      • Albuquerque、New Mexico、美国、87102
        • New Mexico Heart Institute

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 80年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

取样方法

非概率样本

研究人群

Subjects diagnosed with congestive heart failure and admitted to the hospital with a diagnosis of acute decompensated heart failure (ADHF).

描述

Inclusion Criteria:

  • Age ≥ 18 years
  • Admission to the hospital with a primary diagnosis of acute decompensated heart failure
  • Treated with or planned treatment with intravenous diuretics
  • Volume overload, as indicated by at least one of the following clinical signs:

    • Peripheral edema
    • Pulmonary edema on physical examination
    • Pleural effusions on chest x-ray
    • Jugular venous distension on physical examination
    • CVP > 10 cmH2O
    • Presence of third heart sound
  • Able to understand study procedures, agree to participate in the study program and voluntarily provide written informed consent

Exclusion Criteria:

  • Inability or refusal to sign the Subject Informed Consent
  • Age > 80 years
  • Body mass index (BMI) > 40
  • Planned mechanical ventilation during hospitalization
  • Presence of left ventricular assist device (LVAD)
  • Dialysis
  • Pregnancy. All women of childbearing potential must have a negative pregnancy test before enrollment.
  • Parenteral diuretic or other medical treatment for ADHF already administered for more than 12 hours prior to enrollment
  • Skin damage to the optical sampling sites (fingers and dorsal hand), to include tattoos, scars, cuts, or burns extending over more than 30% of the visible tissue
  • Compromised superficial hand veins or proximal venous stenosis
  • Intravenous lines connected to both arms
  • Inability to stand with support, if needed, for 4 minutes
  • Inability to place hand in the venous imaging enclosure due to forearm, elbow, or shoulder injuries, or other physical constraints
  • Inability to wear fingertip or ring sensors on three fingers (of either hand) due to missing fingers, injured fingers, or other physical constraints
  • Persons in police custody or prisoners
  • Major medical or psychiatric condition that would interfere with the ability to complete the study

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:队列
  • 时间观点:横截面

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Accuracy of Estimated Changes in Stroke Volume
大体时间:Retrospective up to 6 months after study completion
Comparison of Stroke Volume Measurement (units of ml) from the optical measurement system with paired Stroke Volume Measurement (ml) from the reference device. Accuracy will be measured in percentage error and Bland-Altman limits of agreement.
Retrospective up to 6 months after study completion

次要结果测量

结果测量
措施说明
大体时间
Accuracy of Central Venous Pressure Measurement
大体时间:Retrospective up to 6 months after study completion
Comparison of Central Venous Pressure Measurement (units of cmH2O) from the optical measurement system with paired Central Venous Pressure Measurement (cmH2O) from the reference device. Accuracy will be measured in percentage error and Bland-Altman limits of agreement.
Retrospective up to 6 months after study completion

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Elena Allen, PhD、Rodin Scientific

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2018年6月9日

初级完成 (实际的)

2018年6月24日

研究完成 (实际的)

2018年7月31日

研究注册日期

首次提交

2018年4月16日

首先提交符合 QC 标准的

2018年5月14日

首次发布 (实际的)

2018年5月24日

研究记录更新

最后更新发布 (实际的)

2019年3月26日

上次提交的符合 QC 标准的更新

2019年3月25日

最后验证

2019年3月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • RS-2018-S01

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

是的

在美国制造并从美国出口的产品

是的

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅